Z-FA-FMK

1. Protease Inhibitor

2. Capable of curing infected cells in vitro

3. Eliminates persistent infection in vitro

 

 

(No antivirals are currently licensed for targeted Reovirus therapy. Z-FA-FMK has been tested only in animal models. Other antiviral candidates have also been tested in animals or have reached early clinical testing.)